Ajay J. Kirtane, MD, SM

Board Certifications: 
Interventional Cardiology, Cardiovascular Disease
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Vascular Medicine, Interventional Cardiology, Transradial Catheterization, Endovascular Intervention, Peripheral Arterial Intervention, Renal Denervation for Hypertension, Stents

Academic Appointments

  • Associate Professor of Medicine at CUMC

Administrative Titles

  • Director, NYP/Columbia Cardiac Catheterization Laboratories
  • Chief Academic Officer, Center for Interventional Vascular Therapy

Ajay J. Kirtane, MD, SM – Interventional Cardiologist

Ajay J. Kirtane, MD, SM, is Associate Professor of Medicine at Columbia University Irving Medical Center (CUIMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUIMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.

In addition to his clinical commitments, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. He is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored over 300 original manuscripts and over 80 reviews and editorials including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology. He is/has been Principal Investigator and serves on the steering committees of several clinical trials in interventional cardiovascular medicine.

Born in Brooklyn, New York, and raised in Bergen County, New Jersey, Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California – San Francisco. He then completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and additionally obtained a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health prior to moving back to Columbia. In his free time, Dr. Kirtane has avid interests in running, tennis, skiing, and music, and lives in New Jersey with his wife, 2 children, and their dog Oliver.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-7060

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • AB, Princeton University
  • 1998 Columbia University College of Physicians and Surgeons
  • MD, Columbia University College of Physicians and Surgeons
  • 2005 Harvard School of Public Health
  • SM, Harvard School of Public Health
  • Internship: University of California-San Francisco Medical Center
  • Residency: University of California-San Francisco Medical Center
  • Fellowship: Harvard Medical School/ Beth Israel Deaconess Medical Center

Board Certifications

  • Interventional Cardiology
  • Cardiovascular Disease

Honors & Awards

Columbia University Medical Center:
2009 Ewig Clinical Teaching Award (three-year funded award), Department of Medicine
2010 Daniel V. Kimberg Junior Faculty Teaching Award, Department of Medicine (given annually to a single recipient)
2011-present Selected to be a Firm Attending on the Neu Firm, Columbia University Department of Medicine
2012 Participant (by nomination/acceptance) in P&S Leadership & Management Institute sponsored by Columbia Doctors, The Columbia Faculty Practice Organization and the Office of the Dean at the College of P&S

American College of Cardiology:
2010 Selected as American College of Cardiology’s Emerging Faculty

Harvard Medical School:
2005 George E. Altman, M.D. and Harriet Altman Annual Cardiology Fellow Award

University of California San Francisco:
2000 Selected as Chief Medical Resident for 2001-2002 academic year

Columbia University College of Physicians and Surgeons:
1996 Gregory Grove Memorial Scholarship (given to the highest-ranking student in the second year class), co-recipient
1998 Externship in Human Rights and Medicine in India
1998 Marie Nercessian Memorial Award for Humanism in Medicine
1998 Membership in Alpha Omega Alpha Society

Princeton University:
1993 Howard Hughes Medical Institute Summer Fellowship
1994 E.R. Squibb and Sons Senior Thesis Prize for Contributions to Scientific Research
1994 Membership in Phi Beta Kappa Society
1994 Membership in Society of Sigma Xi

America's Top Doctor
NY Top Doctor

Research

Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He is/has been Principal Investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.

Grants

THE RADIANCE II PIVOTAL STUDY A STUDY OF THE RECOR MEDICAL PARADISE SYSTEM IN STAGE II HYPERTENSION (P&S Industry Clinical Trial)

Dec 3 2018 - Dec 3 2023

A POST-APPROVAL STUDY OF THE MEDTRONIC RESOLUTE ONYX? ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM (RESOLUTE ONYX POST-APPROVAL STUDY) (P&S Industry Clinical Trial)

Jun 13 2017 - Jun 13 2022

OUTCOMES OF PERCUTANEOUS REVASCULARIZATION FOR MANAGEMENT OF SURGICALLY INELIGIBLE PATIEINTS WITH MULTIVESSEL OR LEFT MAIN CORONARY ARTERY DISEASE: A PROSPECTIVE REGISTRY (P&S Industry Clinical Trial)

Apr 12 2017 - Apr 12 2022

SERVICE AGREEMENT - MEDTRONIC - A 1197024 (C RDN) (P&S Industry Clinical Trial)

Jan 14 2015 - Jan 14 2020

2018 MEDTRONIC INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)

Jul 1 2018 - Jun 30 2019

COMPLEX HIGH-RISK INTERVENTIONAL PROCEDURES (CHIP) (Private)

Jul 1 2018 - Jun 30 2019

PROGNOSTIC SIGNIFICANCE OF NONINVASIVE CARDIAC INDEX AND CEREBRAL PERFUSION ESTIMATES IN COMATOSE SURVIVORS OF OUT-OF-HOSPITAL CARDIAC ARREST (CAPITAL-RETURN) (Private)

Jul 1 2018 - Jun 30 2019

THE USPELLA REGISTRY IS A MULTI-SITE, OBSERVATIONAL REGISTRY FOR COLLECTION OF DE-IDENTIFIED DATA FOR PATIENTS TREATED WITH THE IMPELLA ? 2.5 PERCUTANEOUS CARDIAC SUPPORT SYSTEM. (P&S Industry Clinical Trial)

Oct 9 2013 - Oct 9 2018

CALM-FIM_US CONTROLLING AND LOWERING BLOOD PRESSURE WITH THE MOBIUSHD A PROSPECTIVE MULTICENTER SAFETY STUDY (P&S Industry Clinical Trial)

Jul 18 2013 - Jul 18 2018

MEDTRONIC INTERVENTIONAL CARDIOLOGY FELLOWSHIP (Private)

Jul 1 2017 - Jun 30 2018

HYBRID CORONARY REVASCULARIZATION TRIAL-DCC (Federal Gov)

Jul 1 2017 - Jun 30 2018

HYBRID CORONARY REVASCULARIZATION TRIAL (Federal Gov)

Jul 15 2016 - Jun 30 2017

COMPLEX HIGH-RISK INTERVENTIONAL PROCEDURES (Private)

Jul 1 2016 - Jun 30 2017

SIMPLICITY (P&S Industry Clinical Trial)

Dec 15 2011 - Dec 15 2016

CORONA FELLOWSHIP GRANT (Private)

Jul 1 2015 - Jun 30 2016

DEVELOPMENT OF A SHARED DECISION MAKING TOOL FOR PATIENTS CONSIDERING TRANSCATHETER AORTIC VALVE REPLACEMENT (Private)

Jul 1 2015 - Jun 30 2016

THE NEPHROTIC SYNDROME STUDY NETWORK (Private)

Jul 1 2015 - Jun 30 2016

MINI-AMI (P&S Industry Clinical Trial)

Jun 17 2011 - Jun 17 2016

DESERT: DRUG ELUTING STENT EVENT REGISTRY OF THEOMBOSIS ( THE NATIONAL DES THROMBOSIS REGISTRY) (P&S Industry Clinical Trial)

Jan 19 2010 - Jan 19 2015

DEPRESSION, BIOBEHAVIORAL MECHANISMS, & CHD/MORTALITY OUTCOMES (Federal Gov)

Sep 22 2008 - Nov 30 2014

Selected Publications

  1. Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). JACC Cardiovasc Interv. 2015 Dec 28;8(15):1978-87.
  2. Kirtane AJ, King SB 3rd. Should all stent patients have prolonged dual antiplatelet therapy? JACC Cardiovasc Interv. 2015 May;8(6):873-5.
  3. Kirtane AJ, Kelly CR. Clearing the air on the "smoker's paradox". J Am Coll Cardiol. 2015 Mar 24;65(11):1116-8.
  4. Kirtane AJ, Stone GW. STEMI care in China: a world opportunity. Lancet. 2015 Jan 31;385(9966):400-1.
  5. Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH Jr, Coleman PS, Stoler RC, Papadakos S, Cutlip DE, Mauri L, Kandzari DE; ENDEAVOR IV Investigators. The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013 Apr;6(4):325-33.
  6. Kirtane AJ, Leon MB. The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trialist perspective. Circulation. 2012 Jun 26;125(25):3229-32.
  7. Kirtane AJ, Stone GW. How to minimize stent thrombosis. Circulation. 2011 Sep 13;124(11):1283-7.
  8. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009 Jun 30;119(25):3198-206.
  9. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008 Feb 19;51(7):708-15.
  10. Jeremias A, Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med. 2008 Feb 5;148(3):234-8.
  11. Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM; TIMI Study Group. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol. 2006 Jun 20;47(12):2374-9.
  12. Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jan 18;45(2):321-3.